CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors.
Liang YanXiuyun TianChun-Xiang YeXiaoya GuanBin DongMin ZhaoJianhui WuChun-Yi HaoPublished in: OncoTargets and therapy (2020)
Therefore, CD26 is a potential marker for early diagnosis and a promising therapeutic target in pancreatic tumors.
Keyphrases